Intraoperative use of cell saver devices decreases the rate of hyperlactatemia in patients undergoing cardiac surgery
Objective: This study was aimed to elucidate the effect of the intraoperative cell saver (CS) on hyperlactatemia of patients who underwent cardiac surgery. Design: A sub-analysis of the CS was performed, which is a historial control trial of patients undergoing cardiac surgery. Setting: This was a r...
Main Authors: | Yenong Zhou, Chen Yang, Zhenxiao Jin, Bing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023032061 |
Similar Items
-
The Impact of Intraoperative Hyperlactatemia on Weaning from Cardiopulmonary Bypass in Patients Undergoing on-Pump Coronary Artery Bypass Grafting Surgery: An Observational Study
by: Pierre Zarif Tawadros, et al.
Published: (2024-07-01) -
Impact of retransfusion of blood processed in cell-saver on coagulation versus cardiopulmonary bypass: A prospective observational study using thromboelastography
by: Tomas Vymazal, et al.
Published: (2015-03-01) -
Remifentanil prevents increases of blood glucose and lactate levels during cardiopulmonary bypass in pediatric cardiac surgery
by: Tomohiro Chaki, et al.
Published: (2017-01-01) -
Relation Between Multiplication of Venous Carbon Dioxide Partial Pressure (PvCO2) and the Ratio of Gas Flow to Pump Flow (Ve/Q) with Hyperlactatemia During Cardiopulmonary Bypass
by: Yos Kowara, et al.
Published: (2024-10-01) -
Association of Weight-indexed Conventional Ultrafiltration Volume with Post-operative Lactate in Patients Undergoing Cardiopulmonary Bypass
by: Hamid Gerami, et al.
Published: (2024-09-01)